文献速递肺栓塞与肺血管病

欧洲呼吸学会官方声明:运动中的肺血流动力学

An official European Respiratory Society statement: pulmonary haemodynamics during exercise.
PubMed 文献 · Eur Respir J · 2017-11-22

该声明评估运动肺血流动力学的科学证据,以提供未来推荐基础。右心导管是评估静息和运动肺血流动力学的金标准。运动肺高压可定义为静息平均肺动脉压<25 mmHg且运动时平均肺动脉压>30 mmHg伴总肺阻力>3 Wood单位,代表早期肺血管病、左心疾病、肺病或组合,需临床随访,但缺乏靶向治疗证据。

要点

  • 右心导管是评估运动肺血流动力学的金标准。
  • 运动肺高压定义:静息mPAP<25 mmHg,运动mPAP>30 mmHg且TPR>3 Wood单位。
  • 运动肺高压需临床随访,尤其存在肺高压危险因素时。

核心结论

  • 运动肺高压可描述运动时肺动脉压相对血流过度升高的异常反应,代表早期肺血管病、左心疾病、肺病或其组合。

研究设计与样本

  • 欧洲呼吸学会官方声明,评估运动肺血流动力学领域的科学证据以提供未来推荐基础。

主要发现

  • 右心导管是评估静息和运动肺血流动力学的金标准。
  • 运动超声心动图和心肺运动试验是非侵入性工具,临床应用不断发展。
  • 运动肺高压与静息平均肺动脉压轻度升高相关,需临床随访,尤其存在肺高压危险因素时。
  • 缺乏针对运动肺高压靶向药物治疗的稳健临床证据。

关键数值与推荐

  • 运动肺高压定义:静息平均肺动脉压<25 mmHg且运动时平均肺动脉压>30 mmHg伴总肺阻力>3 Wood单位。

临床怎么用

  • 临床可依据右心导管评估运动肺血流动力学,识别运动肺高压并随访,尤其存在肺高压危险因素时。

局限性

  • 缺乏针对运动肺高压靶向药物治疗的稳健临床证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is growing recognition of the clinical importance of pulmonary haemodynamics during exercise, but several questions remain to be elucidated. The goal of this statement is to assess the scientific evidence in this field in order to provide a basis for future recommendations.Right heart catheterisation is the gold standard method to assess pulmonary haemodynamics at rest and during exercise. Exercise echocardiography and cardiopulmonary exercise testing represent non-invasive tools with evolving clinical applications. The term "exercise pulmonary hypertension" may be the most adequate to describe an abnormal pulmonary haemodynamic response characterised by an excessive pulmonary arterial pressure (PAP) increase in relation to flow during exercise. Exercise pulmonary hypertension may be defined as the presence of resting mean PAP <25 mmHg and mean PAP >30 mmHg during exercise with total pulmonary resistance >3 Wood units. Exercise pulmonary hypertension represents the haemodynamic appearance of early pulmonary vascular disease, left heart disease, lung disease or a combination of these conditions. Exercise pulmonary hypertension is associated with the presence of a modest elevation of resting mean PAP and requires clinical follow-up, particularly if risk factors for pulmonary hypertension are present. There is a lack of robust clinical evidence on targeted medical therapy for exercise pulmonary hypertension.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kovacs G, Herve P, Barbera JA, et al. An official European Respiratory Society statement: pulmonary haemodynamics during exercise. Eur Respir J. 2017. PMID: 29167297. doi:10.1183/13993003.00578-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。